Lilac was founded with the mission of delivering best-in-class cloud and AI/ML powered technology to a healthcare system that urgently needs what these technologies have to offer. We initially focused on a specific set of payer challenges – Medicare Advantage (MA) Stars performance management and quality workflows – but the vision has always been broader: to support organizations across the healthcare ecosystem. Transforming healthcare will take leaps forward by every part of the industry’s value chain – from payers to PBMs to MSOs to providers.
When we were presented with the opportunity to accelerate that vision by combining with an organization with highly aligned values, vision and products, we decided it was too good topass up up. Today, we are excited to announce that Lilac has been acquired by Medisolv.
Combining Medisolv’s industry-leading clinical quality intelligence platform with Lilac’s AI-driven predictive analytics and MA Stars expertise allows us to rapidly develop a new generation of technology to empower health plans and providers to turn quality data into action.
The Problem: Quality Data Exists, But Action Is Hard
Healthcare organizations today have access to more quality data than ever before. Clinical records, claims data, and performance reports are widely available across programs such as:
- Medicare Advantage Stars
- MSSP and ACO programs
- HEDIS and other quality measures
- Emerging patient-reported outcome measures
Yet most organizations still struggle to translate this data into better health outcomes and better business performance.
The challenge starts with fragmented clinical and claims data spread across multiple systems, making it difficult to form a unified view of performance. At the same time, they lack predictive insight into future quality outcomes and face challenges determining which patient care gaps will have the greatest impact. Even when those gaps are identified, operational barriers make it difficult to engage patients effectively at scale.
The Opportunity: Connecting Clinical Intelligence with AI-Driven Analytics
By combining Medisolv and Lilac, we’re working to address a critical gap in value-based care infrastructure. Medisolv brings deep expertise in clinical quality measurement and regulatory reporting, supporting more than 100,000 providers nationwide.
Lilac contributes predictive analytics, claims-based performance insights, and AI-driven patient engagement technology designed to help organizations proactively close care gaps.
Together, these capabilities create a platform that helps healthcare organizations:
- Predict quality performance earlier: AI-driven analytics identify emerging risks across measures like Stars and HEDIS before performance gaps widen.
- Connect clinical and claims insights: Combining these two perspectives creates a more complete picture of patient care and quality performance.
- Scale member/patient engagement: AI-enabled outreach helps organizations engage patients efficiently, collect important quality data, and close care gaps.
- Reduce administrative burden: Automating quality intelligence and outreach allows teams to spend less time assembling reports and more time improving care.
Why This Matters
For health plans, ACOs, and risk-bearing provider groups, success increasingly depends on managing performance across multiple value-based programs simultaneously.
That requires technology capable of:
- Identifying high impact care gaps earlier in the year
- Coordinating outreach across large patient populations
- Aligning clinical and financial performance metrics
- Enabling operational teams to deliver better health outcomes more efficiently
The Medisolv<>Lilac combination is designed to address exactly these needs.
By integrating clinical quality intelligence with predictive analytics and AI-driven workflows, healthcare organizations can move from retrospective reporting to proactive performance improvement.
Looking Ahead
At Lilac, our mission has always been to help healthcare organizations turn data into action using AI.
By joining forces with Medisolv, an organization already trusted by more than 1,800 healthcare organizations and 100,000+ providers nationwide, we can accelerate the development of new capabilities that help health plans and providers:
- Close care gaps faster
- Engage patients more effectively
- Improve quality outcomes
- Succeed in increasingly complex value-based payment models
- Reducing the cost of care while driving quality improvement
Neetu Rajpal, CEO and Co-Founder of Lilac: “We founded Lilac to help healthcare organizations turn data into action through AI. As payers and providers push toward value-based care, we’re excited to bring our predictive analytics and AI capabilities together with Medisolv’s trusted leadership in clinical quality management. By combining our claims-based insights with Medisolv’s deep clinical expertise, we can accelerate the development of a new generation of agentic AI-driven solutions that help healthcare organizations not only measure performance but actively improve it.”
David Lucey, Jr., CEO of Medisolv: “This acquisition marks an important milestone in Medisolv’s evolution. For decades, our mission has been to help healthcare organizations understand and improve their quality performance. With Lilac, we expand that mission from measurement to prediction to impact. By combining clinical quality data, claims analytics, and agentic AI, we are building a platform that not only reports on performance but actively helps providers and payers close gaps in care, reduce administrative burden, and succeed in value-based payment models.”
Reach out here to start a conversation about how the combined Lilac<>Medisolv can help you.
About Medisolv, Inc.
Medisolv is a national leader in healthcare quality data management, helping hospitals, health systems, providers, and ACOs deliver safer, higher-quality care. For more than 25 years, Medisolv has supported the full quality journey across inpatient, outpatient, and ACO programs through its all-in-one quality improvement solution, ENCOR, which supports more than 500 national quality and safety measures required by CMS, The Joint Commission, state agencies, and private payers. Medisolv’s solutions span data abstraction, digital measures, registry reporting, performance analytics, and trusted advisory services. Trusted by more than 1,800 healthcare organizations and 100,000+ providers nationwide, Medisolv is recognized with Best in KLAS, Black Book, and HIMSS Policy Changemaker awards for excellence in client satisfaction and leadership in digital quality measurement. For more information about Medisolv, please visit www.medisolv.com.